Lung fibrosis induced by crystalline silica particles is uncoupled from lung inflammation in NMRI mice

Toxicology Letters

Volumn 203, Issue 2, 2011, Pages 127-134

  Rabolli, Virginie ^a   Lo Re, Sandra ^a   Uwambayinema, Francine ^a   Yakoub, Yousof ^a   Lison, Dominique ^a   Huaux, François ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Anti inflammatory treatment; Inflammatory cytokines; Lung fibrosis; Lung inflammation; Silica; Suppressive cytokines

Indexed keywords

COLLAGEN; CRYSTALLINE SILICA PARTICLE; CYTOKINE; DEXAMETHASONE; FELDENE LIOTABS; INTERLEUKIN 10; INTERLEUKIN 1BETA; KERATINOCYTE CYTOKINE; LACTATE DEHYDROGENASE; MYELOPEROXIDASE; PIROXICAM; SILDENAFIL; SILICON DIOXIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; ENZYME ACTIVITY; FEMALE; LUNG FIBROSIS; LUNG LAVAGE; LYMPHOCYTE COUNT; MACROPHAGE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN SYNTHESIS INHIBITION; SILICOSIS;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; COLLAGEN; CYCLOOXYGENASE INHIBITORS; FEMALE; INTERLEUKIN-10; L-LACTATE DEHYDROGENASE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PIROXICAM; PNEUMONIA; PULMONARY FIBROSIS; PURINES; SILICON DIOXIDE; SULFONES; TRANSFORMING GROWTH FACTOR BETA;

MUS; RATTUS;

EID: 79955467443     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.03.009     Document Type: Article

References (55)

1. Adamson I.Y., Prieditis H., Bowden D.H. Instillation of chemotactic factor to silica-injected lungs lowers interstitial particle content and reduces pulmonary fibrosis. Am. J. Pathol. 1992, 141:319-326.
2. Adamson I.Y., Prieditis H., Bowden D.H. Enhanced clearance of silica from mouse lung after instillation of a leukocyte chemotactic factor. Exp. Lung Res. 1994, 20:223-233.
3. Arafa H.M., Abdel-Wahab M.H., El Shafeey M.F., Badary O.A., Hamada F.M. Anti-fibrotic effect of meloxicam in a murine lung fibrosis model. Eur. J. Pharmacol. 2007, 564:181-189.
4. Barbarin V., Arras M., Misson P., Delos M., McGarry B., Phan S.H., Lison D., Huaux F. Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice. Am. J. Respir. Cell. Mol. Biol. 2004, 31:78-85.
5. Barbarin V., Nihoul A., Misson P., Arras M., Delos M., Leclercq I., Lison D., Huaux F. The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis. Respir. Res. 2005, 6(1):112.
6. Barbarin V., Xing Z., Delos M., Lison D., Huaux F. Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:L841-L848.
7. Beamer C.A., Holian A. Scavenger receptor class A type I/II (CD204) null mice fail to develop fibrosis following silica exposure. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L186-L195.
8. Bonniaud P., Margetts P.J., Kolb M., Schroeder J.A., Kapoun A.M., Damm D., Murphy A., Chakravarty S., Dugar S., Higgins L., Protter A.A., Gauldie J. Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am. J. Respir. Crit. Care Med. 2005, 171:889-898.
9. Borm P.J., Driscoll K. Particles, inflammation and respiratory tract carcinogenesis. Toxicol. Lett. 1996, 88:109-113.
10. Bosma B.M., Metselaar H.J., Nagtzaam N.M., de Haan R., Mancham S., van der Laan L.J., Kuipers E.J., Kwekkeboom J. Dexamethasone transforms lipopolysaccharide-stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin-10 production in T cells. Immunology 2008, 125:91-100.
11. Brooks R.R., Bonk K.R., Decker G.E., Miller K.E. Anti-inflammatory activity of orpanoxin administered orally and topically to rodents. Agents Actions 1985, 16:369-376.
12. Callis A.H., Sohnle P.G., Mandel G.S., Wiessner J., Mandel N.S. Kinetics of inflammatory and fibrotic pulmonary changes in a murine model of silicosis. J. Lab. Clin. Med. 1985, 105:547-553.
13. Chen F., Gong L., Zhang L., Wang H., Qi X., Wu X., Xiao Y., Cai Y., Liu L., Li X., Ren J. Short courses of low dose dexamethasone delay bleomycin-induced lung fibrosis in rats. Eur. J. Pharmacol. 2006, 536:287-295.
14. Di Giuseppe M., Gambelli F., Hoyle G.W., Lungarella G., Studer S.M., Richards T., Yousem S., McCurry K., Dauber J., Kaminski N., Leikauf G., Ortiz L.A. Systemic inhibition of NF-kappaB activation protects from silicosis. PLoS. One 2009, 4:e5689.
15. Dik W.A., McAnulty R.J., Versnel M.A., Naber B.A., Zimmermann L.J., Laurent G.J., Mutsaers S.E. Short course dexamethasone treatment following injury inhibits bleomycin induced fibrosis in rats. Thorax 2003, 58:765-771.
16. DiMatteo M., Reasor M.J. Modulation of silica-induced pulmonary toxicity by dexamethasone-containing liposomes. Toxicol. Appl. Pharmacol. 1997, 142:411-421.
17. Driscoll K.E. Macrophage inflammatory proteins-biology and role in pulmonary inflammation. Exp. Lung Res. 1994, 20:473-490.
18. Duperrier K., Velten F.W., Bohlender J., Demory A., Metharom P., Goerdt S. Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes. Mol. Immunol. 2005, 42:1531-1540.
19. Gasse P., Riteau N., Charron S., Girre S., Fick L., Petrilli V., Tschopp J., Lagente V., Quesniaux V.F., Ryffel B., Couillin I. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 2009, 179:903-913.
20. Gharaee-Kermani M., Hu B., Phan S.H., Gyetko M.R. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast. Curr. Med. Chem. 2009, 16:1400-1417.
21. Goodman G.B., Kaplan P.D., Stachura I., Castranova V., Pailes W.H., Lapp N.L. Acute silicosis responding to corticosteroid therapy. Chest 1992, 101:366-370.
22. Greenberg M.I., Waksman J., Curtis J. Silicosis: a review. Dis. Mon. 2007, 53:394-416.
23. Hardie W.D., Glasser S.W., Hagood J.S. Emerging concepts in the pathogenesis of lung fibrosis. Am. J. Pathol. 2009, 175:3-16.
24. Helmig S., Belwe A., Schneider J. Association of transforming growth factor beta1 gene polymorphisms and asbestos-induced fibrosis and tumors. J. Investig. Med. 2009, 57:655-661.
25. Huang T.J., Newton R., Haddad E.B., Chung K.F. Differential regulation of cytokine expression after allergen exposure of sensitized rats by cyclosporin A and corticosteroids: relationship to bronchial hyperresponsiveness. J. Allergy Clin. Immunol. 1999, 104:644-652.
26. Huaux F. New developments in the understanding of immunology in silicosis. Curr. Opin. Allergy Clin. Immunol. 2007, 7:168-173.
27. Huaux F., Louahed J., Hudspith B., Meredith C., Delos M., Renauld J.C., Lison D. Role of interleukin-10 in the lung response to silica in mice. Am. J. Respir. Cell. Mol. Biol. 1998, 18:51-59.
28. Huaux F., Arras M., Vink A., Renauld J.C., Lison D. Soluble tumor necrosis factor (TNF) receptors p55 and p75 and interleukin-10 downregulate TNF-alpha activity during the lung response to silica particles in NMRI mice. Am. J. Respir. Cell. Mol. Biol. 1999, 21:137-145.
29. Huaux F., Arras M., Tomasi D., Barbarin V., Delos M., Coutelier J.P., Vink A., Phan S.H., Renauld J.C., Lison D. A profibrotic function of IL-12p40 in experimental pulmonary fibrosis. J. Immunol. 2002, 169:2653-2661.
30. IARC, 1997. Silica, some silicates, coal dusts and para-amid fibrils. 68. Lyon. France.
31. Jagirdar J., Begin R., Dufresne A., Goswami S., Lee T.C., Rom W.N. Transforming growth factor-beta (TGF-beta) in silicosis. Am. J. Respir. Crit Care Med. 1996, 154:1076-1081.
32. Kimura T., Ishii Y., Yoh K., Morishima Y., Iizuka T., Kiwamoto T., Matsuno Y., Homma S., Nomura A., Sakamoto T., Takahashi S., Sekizawa K. Overexpression of the transcription factor GATA-3 enhances the development of pulmonary fibrosis. Am. J. Pathol. 2006, 169:96-104.
33. Kolb M., Margetts P.J., Anthony D.C., Pitossi F., Gauldie J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J. Clin. Invest. 2001, 107:1529-1536.
34. Lee C.G., Homer R.J., Cohn L., Link H., Jung S., Craft J.E., Graham B.S., Johnson T.R., Elias J.A. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J. Biol. Chem. 2002, 277:35466-35474.
35. Li M.O., Flavell R.A. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 2008, 28:468-476.
36. Li M.O., Flavell R.A. TGF-beta: a master of all T cell trades. Cell. 2008, 134:392-404.
37. Lundblad L.K., Thompson-Figueroa J., Leclair T., Sullivan M.J., Poynter M.E., Irvin C.G., Bates J.H. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am. J. Respir. Crit. Care Med. 2005, 171:1363-1370.
38. Porter D.W., Hubbs A.F., Mercer R., Robinson V.A., Ramsey D., McLaurin J., Khan A., Battelli L., Brumbaugh K., Teass A., Castranova V. Progression of lung inflammation and damage in rats after cessation of silica inhalation. Toxicol. Sci. 2004, 79:370-380.
39. Porter D.W., Ye J., Ma J., Barger M., Robinson V.A., Ramsey D., McLaurin J., Khan A., Landsittel D., Teass A., Castranova V. Time course of pulmonary response of rats to inhalation of crystalline silica: NF-kappa B activation, inflammation, cytokine production, and damage. Inhal. Toxicol. 2002, 14:349-367.
40. Rudd R.M., Haslam P.L., Turner-Warwick M. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am. Rev. Respir. Dis. 1981, 124:1-8.
41. Selman M., Pardo A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir. Res. 2002, 3:3.
42. Sharma S.K., Pande J.N., Verma K. Effect of prednisolone treatment in chronic silicosis. Am. Rev. Respir. Dis. 1991, 143:814-821.
43. Shi M.N., Huang Y.H., Zheng W.D., Zhang L.J., Chen Z.X., Wang X.Z. Relationship between transforming growth factor beta1 and anti-fibrotic effect of interleukin-10. World J. Gastroenterol. 2006, 12:2357-2362.
44. Sun L., Louie M.C., Vannella K.M., Wilke C.A., Levine A.M., Moore B.B., Shanley T.P. New concepts of IL-10 induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. Am. J. Physiol Lung Cell Mol. Physiol. 2011, 3:L341-L353.
45. Tabata C., Kadokawa Y., Tabata R., Takahashi M., Okoshi K., Sakai Y., Mishima M., Kubo H. All-trans-retinoic acid prevents radiation- or bleomycin-induced pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2006, 174:1352-1360.
46. Thakur S.A., Beamer C.A., Migliaccio C.T., Holian A. Critical role of MARCO in crystalline silica-induced pulmonary inflammation. Toxicol. Sci. 2009, 108:462-471.
47. Thakur S.A., Hamilton R.F., Holian A. Role of scavenger receptor a family in lung inflammation from exposure to environmental particles. J. Immunotoxicol. 2008, 5:151-157.
48. van Ravenzwaay B., Landsiedel R., Fabian E., Burkhardt S., Strauss V., Ma-Hock L. Comparing fate and effects of three particles of different surface properties: nano-TiO(2), pigmentary TiO(2) and quartz. Toxicol. Lett. 2009, 186:152-159.
49. Wagner G.R. Asbestosis and silicosis. Lancet 1997, 349:1311-1315.
50. Wang X., Chen Y., Lv L., Chen J. Silencing CD36 gene expression results in the inhibition of latent-TGF-beta1 activation and suppression of silica-induced lung fibrosis in the rat. Respir. Res. 2009, 10:36.
51. Wiethoff A.J., Reed K.L., Webb T.R., Warheit D.B. Assessing the role of neutrophil apoptosis in the resolution of particle-induced pulmonary inflammation. Inhal. Toxicol. 2003, 15:1231-1246.
52. Wigenstam E., Rocksen D., Ekstrand-Hammarstrom B., Bucht A. Treatment with dexamethasone or liposome-encapsuled vitamin E provides beneficial effects after chemical-induced lung injury. Inhal. Toxicol. 2009, 21:958-964.
53. Yildirim A., Ersoy Y., Ercan F., Atukeren P., Gumustas K., Uslu U., Alican I. Phosphodiesterase-5 inhibition by sildenafil citrate in a rat model of bleomycin-induced lung fibrosis. Pulm. Pharmacol. Ther. 2009, 3:215-221.
54. Zeidler P.C., Hubbs A., Battelli L., Castranova V. Role of inducible nitric oxide synthase-derived nitric oxide in silica-induced pulmonary inflammation and fibrosis. J. Toxicol. Environ. Health. A 2004, 67:1001-1026.
55. Zhu Z., Lee C.G., Zheng T., Chupp G., Wang J., Homer R.J., Noble P.W., Hamid Q., Elias J.A. Airway inflammation and remodeling in asthma. Lessons from interleukin 11 and interleukin 13 transgenic mice. Am. J. Respir. Crit Care Med. 2001, 164:S67-S70.